Crossmark

Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer

Crossref DOI link: https://doi.org/10.1007/s00280-016-3000-3

Published Online: 2016-04-16

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Said, Rabih

Kakadiaris, Eugenia

Piha-Paul, Sarina

Fu, Siqing

Falchook, Gerald

Janku, Filip

Wheler, Jennifer J.

Zinner, Ralph

Hong, David S.

Kurzrock, Razelle

Tsimberidou, Apostolia M.
Funding

Funding for this research was provided by:

Celgene
License Information

Text and Data Mining valid from 2016-04-16